Phathom Pharmaceuticals

Develops and commercializes treatments for gastrointestinal acid-related disorders.

PharmaceuticalsBiotechnology phathompharma.com ↗

Company facts

Founded
2018
Employees
371
Headquarters
United States
Type
Public
Listed
Nasdaq: PHAT